

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 8.98437904 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 8.03118426 |
| 3 | omega-hydroxylase P450 pathway (GO:0097267) | 7.89733078 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.45044172 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.45044172 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 7.11939256 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.11939256 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.70955459 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.48427605 |
| 10 | tryptophan catabolic process (GO:0006569) | 6.04789328 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 6.04789328 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 6.04789328 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.92007253 |
| 14 | drug metabolic process (GO:0017144) | 5.90440091 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.82914919 |
| 16 | oxidative demethylation (GO:0070989) | 5.82375164 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 5.72241765 |
| 18 | tryptophan metabolic process (GO:0006568) | 5.70213104 |
| 19 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.65805171 |
| 20 | protein carboxylation (GO:0018214) | 5.65805171 |
| 21 | * urea metabolic process (GO:0019627) | 5.65227581 |
| 22 | * urea cycle (GO:0000050) | 5.65227581 |
| 23 | glyoxylate metabolic process (GO:0046487) | 5.62277994 |
| 24 | complement activation, alternative pathway (GO:0006957) | 5.55739735 |
| 25 | high-density lipoprotein particle remodeling (GO:0034375) | 5.54139136 |
| 26 | alpha-linolenic acid metabolic process (GO:0036109) | 5.50142074 |
| 27 | regulation of fibrinolysis (GO:0051917) | 5.43607275 |
| 28 | regulation of protein activation cascade (GO:2000257) | 5.37899953 |
| 29 | sulfur amino acid catabolic process (GO:0000098) | 5.22693651 |
| 30 | phenylpropanoid metabolic process (GO:0009698) | 5.20918149 |
| 31 | cysteine metabolic process (GO:0006534) | 5.16702960 |
| 32 | * nitrogen cycle metabolic process (GO:0071941) | 5.14392482 |
| 33 | regulation of complement activation (GO:0030449) | 5.04165991 |
| 34 | regulation of plasminogen activation (GO:0010755) | 4.99652138 |
| 35 | serine family amino acid catabolic process (GO:0009071) | 4.97534744 |
| 36 | bile acid metabolic process (GO:0008206) | 4.97452467 |
| 37 | regulation of cholesterol esterification (GO:0010872) | 4.96777889 |
| 38 | negative regulation of protein activation cascade (GO:2000258) | 4.94549856 |
| 39 | regulation of humoral immune response (GO:0002920) | 4.94012657 |
| 40 | reverse cholesterol transport (GO:0043691) | 4.88785160 |
| 41 | aromatic amino acid family metabolic process (GO:0009072) | 4.87431865 |
| 42 | negative regulation of hemostasis (GO:1900047) | 4.86732658 |
| 43 | negative regulation of blood coagulation (GO:0030195) | 4.86732658 |
| 44 | regulation of triglyceride catabolic process (GO:0010896) | 4.86650782 |
| 45 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.84360114 |
| 46 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.84151385 |
| 47 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.84151385 |
| 48 | plasma lipoprotein particle remodeling (GO:0034369) | 4.83399693 |
| 49 | protein-lipid complex remodeling (GO:0034368) | 4.83399693 |
| 50 | macromolecular complex remodeling (GO:0034367) | 4.83399693 |
| 51 | tyrosine metabolic process (GO:0006570) | 4.77378018 |
| 52 | phospholipid efflux (GO:0033700) | 4.76907911 |
| 53 | homocysteine metabolic process (GO:0050667) | 4.66115959 |
| 54 | negative regulation of sterol transport (GO:0032372) | 4.57385083 |
| 55 | negative regulation of cholesterol transport (GO:0032375) | 4.57385083 |
| 56 | amino-acid betaine metabolic process (GO:0006577) | 4.56066516 |
| 57 | plasma lipoprotein particle clearance (GO:0034381) | 4.54471516 |
| 58 | triglyceride homeostasis (GO:0070328) | 4.54106069 |
| 59 | acylglycerol homeostasis (GO:0055090) | 4.54106069 |
| 60 | * alpha-amino acid catabolic process (GO:1901606) | 4.48524039 |
| 61 | alkaloid metabolic process (GO:0009820) | 4.44514777 |
| 62 | ethanol metabolic process (GO:0006067) | 4.43277416 |
| 63 | lysine catabolic process (GO:0006554) | 4.42050991 |
| 64 | lysine metabolic process (GO:0006553) | 4.42050991 |
| 65 | positive regulation of hemostasis (GO:1900048) | 4.40467099 |
| 66 | positive regulation of blood coagulation (GO:0030194) | 4.40467099 |
| 67 | negative regulation of coagulation (GO:0050819) | 4.39223864 |
| 68 | negative regulation of wound healing (GO:0061045) | 4.38075277 |
| 69 | S-adenosylmethionine metabolic process (GO:0046500) | 4.32093016 |
| 70 | cholesterol efflux (GO:0033344) | 4.29569702 |
| 71 | indolalkylamine metabolic process (GO:0006586) | 4.28711699 |
| 72 | hormone catabolic process (GO:0042447) | 4.27410251 |
| 73 | bile acid and bile salt transport (GO:0015721) | 4.25355536 |
| 74 | coenzyme catabolic process (GO:0009109) | 4.24379168 |
| 75 | cellular glucuronidation (GO:0052695) | 4.24288714 |
| 76 | cytolysis (GO:0019835) | 4.23074507 |
| 77 | cellular ketone body metabolic process (GO:0046950) | 4.22861232 |
| 78 | imidazole-containing compound metabolic process (GO:0052803) | 4.21439967 |
| 79 | glycine metabolic process (GO:0006544) | 4.20695425 |
| 80 | cellular biogenic amine catabolic process (GO:0042402) | 4.19954223 |
| 81 | amine catabolic process (GO:0009310) | 4.19954223 |
| 82 | negative regulation of complement activation (GO:0045916) | 4.14717626 |
| 83 | fibrinolysis (GO:0042730) | 4.13617340 |
| 84 | * cellular amino acid catabolic process (GO:0009063) | 4.10964467 |
| 85 | glutamate metabolic process (GO:0006536) | 4.08938369 |
| 86 | benzene-containing compound metabolic process (GO:0042537) | 4.07069368 |
| 87 | positive regulation of coagulation (GO:0050820) | 4.06150952 |
| 88 | plasma lipoprotein particle assembly (GO:0034377) | 4.05476440 |
| 89 | low-density lipoprotein particle remodeling (GO:0034374) | 4.04286885 |
| 90 | aldehyde catabolic process (GO:0046185) | 4.00688603 |
| 91 | ethanol oxidation (GO:0006069) | 3.98499356 |
| 92 | serine family amino acid metabolic process (GO:0009069) | 3.98226445 |
| 93 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.97090503 |
| 94 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.92734232 |
| 95 | cellular modified amino acid catabolic process (GO:0042219) | 3.89858595 |
| 96 | complement activation (GO:0006956) | 3.85070320 |
| 97 | complement activation, classical pathway (GO:0006958) | 3.82316557 |
| 98 | protein activation cascade (GO:0072376) | 3.81947204 |
| 99 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.81411223 |
| 100 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.81411223 |
| 101 | drug catabolic process (GO:0042737) | 3.80728034 |
| 102 | cofactor catabolic process (GO:0051187) | 3.80038064 |
| 103 | negative regulation of lipase activity (GO:0060192) | 3.80034681 |
| 104 | blood coagulation, intrinsic pathway (GO:0007597) | 3.79096838 |
| 105 | * arginine metabolic process (GO:0006525) | 3.78702133 |
| 106 | positive regulation of lipid catabolic process (GO:0050996) | 3.78435564 |
| 107 | acute inflammatory response (GO:0002526) | 3.78151359 |
| 108 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.77174980 |
| 109 | glucuronate metabolic process (GO:0019585) | 3.76897896 |
| 110 | uronic acid metabolic process (GO:0006063) | 3.76897896 |
| 111 | serine family amino acid biosynthetic process (GO:0009070) | 3.75406615 |
| 112 | phospholipid homeostasis (GO:0055091) | 3.74086706 |
| 113 | cholesterol homeostasis (GO:0042632) | 3.70749908 |
| 114 | plasma lipoprotein particle organization (GO:0071827) | 3.69596014 |
| 115 | sterol homeostasis (GO:0055092) | 3.65690019 |
| 116 | ketone body metabolic process (GO:1902224) | 3.64927215 |
| 117 | protein-lipid complex assembly (GO:0065005) | 3.64875995 |
| 118 | * organic acid catabolic process (GO:0016054) | 3.61186213 |
| 119 | * carboxylic acid catabolic process (GO:0046395) | 3.61186213 |
| 120 | opsonization (GO:0008228) | 3.59676326 |
| 121 | acute-phase response (GO:0006953) | 3.59466248 |
| 122 | regulation of bile acid biosynthetic process (GO:0070857) | 3.56660590 |
| 123 | response to mercury ion (GO:0046689) | 3.55041823 |
| 124 | regulation of acute inflammatory response (GO:0002673) | 3.53413548 |
| 125 | short-chain fatty acid metabolic process (GO:0046459) | 3.52323453 |
| 126 | flavonoid metabolic process (GO:0009812) | 3.52158179 |
| 127 | acetyl-CoA metabolic process (GO:0006084) | 3.52084743 |
| 128 | heme transport (GO:0015886) | 3.50356447 |
| 129 | lipoprotein metabolic process (GO:0042157) | 3.50180857 |
| 130 | regulation of lipoprotein particle clearance (GO:0010984) | 3.48802447 |
| 131 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.41162584 |
| 132 | intestinal cholesterol absorption (GO:0030299) | 3.39393839 |
| 133 | xenobiotic metabolic process (GO:0006805) | 3.38831554 |
| 134 | negative regulation of humoral immune response (GO:0002921) | 3.38424695 |
| 135 | steroid catabolic process (GO:0006706) | 3.38201211 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.22065029 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.03620263 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.83292859 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.36813363 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.16565088 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.00118261 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.80614302 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.92090039 |
| 9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.90790949 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.00933630 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.6945876 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.95125478 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.91387299 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.66015499 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.55289749 |
| 16 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.55138300 |
| 17 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.46075771 |
| 18 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.34516271 |
| 19 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.34133738 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.30403492 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.29609646 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.20249539 |
| 23 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.15742132 |
| 24 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.14726442 |
| 25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.14257962 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.13331502 |
| 27 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.12427488 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.10307865 |
| 29 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06286583 |
| 30 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.06223391 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.03749838 |
| 32 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.00136484 |
| 33 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.00129689 |
| 34 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99780185 |
| 35 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.92601141 |
| 36 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.91638946 |
| 37 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.91108615 |
| 38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.90124156 |
| 39 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.89023623 |
| 40 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.88607498 |
| 41 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.87781761 |
| 42 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85926038 |
| 43 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84178293 |
| 44 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.83593827 |
| 45 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.79276283 |
| 46 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.78507263 |
| 47 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.76116924 |
| 48 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.76081996 |
| 49 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.75470312 |
| 50 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.75080567 |
| 51 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.74551216 |
| 52 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.74551216 |
| 53 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.73967682 |
| 54 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.72575125 |
| 55 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.71279238 |
| 56 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.70671650 |
| 57 | NFYA_21822215_ChIP-Seq_K562_Human | 0.70297967 |
| 58 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.69879836 |
| 59 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.69362742 |
| 60 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68730069 |
| 61 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.67274028 |
| 62 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.66623076 |
| 63 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.66451633 |
| 64 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.66273352 |
| 65 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.66162448 |
| 66 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.66106035 |
| 67 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.65883212 |
| 68 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.65547445 |
| 69 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.64902616 |
| 70 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.64400855 |
| 71 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.63731163 |
| 72 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.63122573 |
| 73 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.62339745 |
| 74 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.61729891 |
| 75 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.61679499 |
| 76 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.61395779 |
| 77 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.61382807 |
| 78 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.61072066 |
| 79 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.60965636 |
| 80 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.60883214 |
| 81 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.60838876 |
| 82 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.59948234 |
| 83 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59828561 |
| 84 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.59826298 |
| 85 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.59519087 |
| 86 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.59434237 |
| 87 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.59371392 |
| 88 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.59225425 |
| 89 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58871799 |
| 90 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.58585830 |
| 91 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.58226808 |
| 92 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.58072359 |
| 93 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.58050970 |
| 94 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.57628752 |
| 95 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.57552256 |
| 96 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.56658689 |
| 97 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.56420977 |
| 98 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.56251139 |
| 99 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.55996873 |
| 100 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.55755010 |
| 101 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.55400649 |
| 102 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.55330504 |
| 103 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.55155753 |
| 104 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.54946251 |
| 105 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.53841223 |
| 106 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.53764033 |
| 107 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.53011602 |
| 108 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.52870946 |
| 109 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52512317 |
| 110 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.52357676 |
| 111 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.51779474 |
| 112 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51585644 |
| 113 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.50764435 |
| 114 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.50268120 |
| 115 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.49828079 |
| 116 | GATA1_19941826_ChIP-Seq_K562_Human | 0.48596699 |
| 117 | GATA2_19941826_ChIP-Seq_K562_Human | 0.47750405 |
| 118 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.47650978 |
| 119 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.46157440 |
| 120 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.45972483 |
| 121 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.45521768 |
| 122 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.45453745 |
| 123 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.45057058 |
| 124 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.43994988 |
| 125 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.43563257 |
| 126 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.43302713 |
| 127 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.42953704 |
| 128 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.42818192 |
| 129 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.42176174 |
| 130 | CBP_21632823_ChIP-Seq_H3396_Human | 0.41642437 |
| 131 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40001842 |
| 132 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.39496501 |
| 133 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.39391148 |
| 134 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.39032990 |
| 135 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.38440442 |
| 136 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.38161490 |
| 137 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.37381470 |
| 138 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.37229730 |
| 139 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.36087489 |
| 140 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.36051704 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.09224895 |
| 2 | MP0005360_urolithiasis | 7.28459907 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.28909106 |
| 4 | MP0005365_abnormal_bile_salt | 6.08660797 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.97980353 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.16033141 |
| 7 | MP0003252_abnormal_bile_duct | 3.82807373 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.56189602 |
| 9 | MP0009840_abnormal_foam_cell | 3.49946795 |
| 10 | MP0005083_abnormal_biliary_tract | 3.00537424 |
| 11 | MP0003195_calcinosis | 2.82036376 |
| 12 | * MP0005332_abnormal_amino_acid | 2.67154653 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.52732999 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.38670866 |
| 15 | MP0000609_abnormal_liver_physiology | 2.19567207 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.14245358 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.09065585 |
| 18 | MP0005319_abnormal_enzyme/_coenzyme | 1.85670206 |
| 19 | MP0003868_abnormal_feces_composition | 1.83091131 |
| 20 | MP0009697_abnormal_copulation | 1.67950431 |
| 21 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.58866855 |
| 22 | MP0003011_delayed_dark_adaptation | 1.52492550 |
| 23 | MP0005451_abnormal_body_composition | 1.52446941 |
| 24 | * MP0001764_abnormal_homeostasis | 1.48520440 |
| 25 | MP0003705_abnormal_hypodermis_morpholog | 1.34895454 |
| 26 | MP0003186_abnormal_redox_activity | 1.34188654 |
| 27 | MP0000604_amyloidosis | 1.29832974 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 1.27041526 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.26558230 |
| 30 | * MP0000598_abnormal_liver_morphology | 1.15702499 |
| 31 | MP0009764_decreased_sensitivity_to | 1.15566699 |
| 32 | MP0002254_reproductive_system_inflammat | 1.10386938 |
| 33 | MP0009763_increased_sensitivity_to | 1.07670748 |
| 34 | MP0009785_altered_susceptibility_to | 1.06877924 |
| 35 | MP0005647_abnormal_sex_gland | 1.04573469 |
| 36 | * MP0002138_abnormal_hepatobiliary_system | 1.03921152 |
| 37 | MP0008469_abnormal_protein_level | 1.00627909 |
| 38 | MP0001915_intracranial_hemorrhage | 0.95647283 |
| 39 | MP0005408_hypopigmentation | 0.94358312 |
| 40 | MP0003436_decreased_susceptibility_to | 0.93454540 |
| 41 | MP0005636_abnormal_mineral_homeostasis | 0.91039203 |
| 42 | * MP0009642_abnormal_blood_homeostasis | 0.89563380 |
| 43 | MP0010368_abnormal_lymphatic_system | 0.89043735 |
| 44 | MP0003690_abnormal_glial_cell | 0.85592169 |
| 45 | MP0005464_abnormal_platelet_physiology | 0.79300235 |
| 46 | MP0002078_abnormal_glucose_homeostasis | 0.77402801 |
| 47 | MP0005084_abnormal_gallbladder_morpholo | 0.77025412 |
| 48 | MP0009053_abnormal_anal_canal | 0.75802702 |
| 49 | * MP0005376_homeostasis/metabolism_phenot | 0.75400371 |
| 50 | MP0009765_abnormal_xenobiotic_induced | 0.74983543 |
| 51 | MP0005670_abnormal_white_adipose | 0.72788045 |
| 52 | MP0006036_abnormal_mitochondrial_physio | 0.72476752 |
| 53 | MP0005334_abnormal_fat_pad | 0.71808730 |
| 54 | MP0005187_abnormal_penis_morphology | 0.70804377 |
| 55 | MP0002971_abnormal_brown_adipose | 0.69709158 |
| 56 | MP0003303_peritoneal_inflammation | 0.69182709 |
| 57 | MP0001851_eye_inflammation | 0.67432013 |
| 58 | MP0003724_increased_susceptibility_to | 0.67297418 |
| 59 | MP0004130_abnormal_muscle_cell | 0.67261458 |
| 60 | MP0005220_abnormal_exocrine_pancreas | 0.66964002 |
| 61 | MP0003075_altered_response_to | 0.66477807 |
| 62 | MP0005535_abnormal_body_temperature | 0.64783161 |
| 63 | MP0001756_abnormal_urination | 0.64368490 |
| 64 | MP0003329_amyloid_beta_deposits | 0.63679205 |
| 65 | MP0005023_abnormal_wound_healing | 0.62295998 |
| 66 | MP0005058_abnormal_lysosome_morphology | 0.61392306 |
| 67 | MP0000639_abnormal_adrenal_gland | 0.60042176 |
| 68 | MP0002876_abnormal_thyroid_physiology | 0.59856013 |
| 69 | MP0005248_abnormal_Harderian_gland | 0.59554644 |
| 70 | MP0001545_abnormal_hematopoietic_system | 0.56596287 |
| 71 | MP0005397_hematopoietic_system_phenotyp | 0.56596287 |
| 72 | MP0005266_abnormal_metabolism | 0.55639894 |
| 73 | MP0001661_extended_life_span | 0.55260734 |
| 74 | * MP0005025_abnormal_response_to | 0.55228475 |
| 75 | MP0002282_abnormal_trachea_morphology | 0.54353806 |
| 76 | MP0010234_abnormal_vibrissa_follicle | 0.53842187 |
| 77 | MP0004782_abnormal_surfactant_physiolog | 0.53763187 |
| 78 | MP0003638_abnormal_response/metabolism_ | 0.52741061 |
| 79 | MP0005395_other_phenotype | 0.52282520 |
| 80 | MP0003879_abnormal_hair_cell | 0.51909142 |
| 81 | MP0002136_abnormal_kidney_physiology | 0.51411559 |
| 82 | MP0005448_abnormal_energy_balance | 0.51335345 |
| 83 | MP0005166_decreased_susceptibility_to | 0.51298856 |
| 84 | MP0006082_CNS_inflammation | 0.50434830 |
| 85 | MP0000685_abnormal_immune_system | 0.49455645 |
| 86 | MP0002796_impaired_skin_barrier | 0.49443520 |
| 87 | MP0001845_abnormal_inflammatory_respons | 0.48818781 |
| 88 | MP0008873_increased_physiological_sensi | 0.48571359 |
| 89 | MP0003878_abnormal_ear_physiology | 0.46975342 |
| 90 | MP0005377_hearing/vestibular/ear_phenot | 0.46975342 |
| 91 | MP0005501_abnormal_skin_physiology | 0.46052126 |
| 92 | MP0003718_maternal_effect | 0.45174489 |
| 93 | MP0002928_abnormal_bile_duct | 0.45112450 |
| 94 | MP0008874_decreased_physiological_sensi | 0.43061993 |
| 95 | MP0000249_abnormal_blood_vessel | 0.42949408 |
| 96 | MP0001881_abnormal_mammary_gland | 0.42032718 |
| 97 | MP0004381_abnormal_hair_follicle | 0.41730237 |
| 98 | MP0002822_catalepsy | 0.40783753 |
| 99 | MP0006035_abnormal_mitochondrial_morpho | 0.40521144 |
| 100 | MP0003953_abnormal_hormone_level | 0.39955385 |
| 101 | * MP0002419_abnormal_innate_immunity | 0.38574324 |
| 102 | MP0000579_abnormal_nail_morphology | 0.38280920 |
| 103 | MP0002168_other_aberrant_phenotype | 0.37832370 |
| 104 | MP0004883_abnormal_blood_vessel | 0.37305266 |
| 105 | MP0000467_abnormal_esophagus_morphology | 0.36620375 |
| 106 | MP0003453_abnormal_keratinocyte_physiol | 0.36612995 |
| 107 | MP0005164_abnormal_response_to | 0.36027371 |
| 108 | MP0005666_abnormal_adipose_tissue | 0.36021898 |
| 109 | MP0008872_abnormal_physiological_respon | 0.34899094 |
| 110 | MP0004947_skin_inflammation | 0.34613178 |
| 111 | MP0002132_abnormal_respiratory_system | 0.34233606 |
| 112 | MP0001853_heart_inflammation | 0.33358889 |
| 113 | MP0001533_abnormal_skeleton_physiology | 0.33262023 |
| 114 | MP0009115_abnormal_fat_cell | 0.32935175 |
| 115 | MP0001243_abnormal_dermal_layer | 0.32588089 |
| 116 | MP0000230_abnormal_systemic_arterial | 0.32293533 |
| 117 | MP0000858_altered_metastatic_potential | 0.30788611 |
| 118 | MP0003172_abnormal_lysosome_physiology | 0.30074306 |
| 119 | MP0002332_abnormal_exercise_endurance | 0.29804162 |
| 120 | MP0001800_abnormal_humoral_immune | 0.28839695 |
| 121 | MP0009931_abnormal_skin_appearance | 0.28311503 |
| 122 | MP0002249_abnormal_larynx_morphology | 0.27593089 |
| 123 | MP0010155_abnormal_intestine_physiology | 0.27237556 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.53507532 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.25529141 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.02265385 |
| 4 | * Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.57948216 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.56260318 |
| 6 | Xanthomatosis (HP:0000991) | 6.28856710 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.24078980 |
| 8 | Complement deficiency (HP:0004431) | 5.68725419 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.55524292 |
| 10 | Joint hemorrhage (HP:0005261) | 5.16930182 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.70442755 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.63933933 |
| 13 | Epidermoid cyst (HP:0200040) | 4.49067573 |
| 14 | Abnormality of complement system (HP:0005339) | 4.38653425 |
| 15 | * Hyperammonemia (HP:0001987) | 4.35846212 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.35812953 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.18487110 |
| 18 | Hyperglycinemia (HP:0002154) | 4.17175067 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 4.16346731 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.12823263 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.09336615 |
| 22 | Ketosis (HP:0001946) | 4.07214657 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.98731141 |
| 24 | Fat malabsorption (HP:0002630) | 3.97050408 |
| 25 | Systemic lupus erythematosus (HP:0002725) | 3.83283012 |
| 26 | Hypoglycemic coma (HP:0001325) | 3.74553708 |
| 27 | Abnormality of the intrinsic pathway (HP:0010989) | 3.69963604 |
| 28 | Hyperglycinuria (HP:0003108) | 3.67497465 |
| 29 | Abnormality of glycine metabolism (HP:0010895) | 3.65162705 |
| 30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.65162705 |
| 31 | Hypercholesterolemia (HP:0003124) | 3.63569111 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.54925835 |
| 33 | * Abnormality of pyrimidine metabolism (HP:0004353) | 3.45682451 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.27818638 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.24979217 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.20956731 |
| 37 | Myocardial infarction (HP:0001658) | 3.20363940 |
| 38 | Osteomalacia (HP:0002749) | 3.12753097 |
| 39 | Glomerulonephritis (HP:0000099) | 3.01594840 |
| 40 | Steatorrhea (HP:0002570) | 3.00943237 |
| 41 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.98355946 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 2.94558705 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 2.93735750 |
| 44 | Spontaneous abortion (HP:0005268) | 2.91839825 |
| 45 | Ketoacidosis (HP:0001993) | 2.89289866 |
| 46 | * Abnormality of nucleobase metabolism (HP:0010932) | 2.88686887 |
| 47 | Skin nodule (HP:0200036) | 2.86279654 |
| 48 | Delayed CNS myelination (HP:0002188) | 2.84366042 |
| 49 | Gangrene (HP:0100758) | 2.84139020 |
| 50 | Purpura (HP:0000979) | 2.81450144 |
| 51 | Hypochromic microcytic anemia (HP:0004840) | 2.73964557 |
| 52 | Vascular calcification (HP:0004934) | 2.65478398 |
| 53 | Abnormality of purine metabolism (HP:0004352) | 2.62779813 |
| 54 | Metabolic acidosis (HP:0001942) | 2.61503636 |
| 55 | Mitral stenosis (HP:0001718) | 2.49803648 |
| 56 | Lethargy (HP:0001254) | 2.47325047 |
| 57 | Fair hair (HP:0002286) | 2.47036523 |
| 58 | Amyloidosis (HP:0011034) | 2.45587976 |
| 59 | Gingival bleeding (HP:0000225) | 2.44675833 |
| 60 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.43411239 |
| 61 | Dicarboxylic aciduria (HP:0003215) | 2.43411239 |
| 62 | Hypoglycemic seizures (HP:0002173) | 2.40280122 |
| 63 | Spastic diplegia (HP:0001264) | 2.39812965 |
| 64 | Abnormal gallbladder morphology (HP:0012437) | 2.38079933 |
| 65 | Menorrhagia (HP:0000132) | 2.37596615 |
| 66 | Acanthocytosis (HP:0001927) | 2.36672024 |
| 67 | Gout (HP:0001997) | 2.35793783 |
| 68 | Epistaxis (HP:0000421) | 2.34798991 |
| 69 | Cardiovascular calcification (HP:0011915) | 2.34274427 |
| 70 | Cholelithiasis (HP:0001081) | 2.31979211 |
| 71 | Reduced antithrombin III activity (HP:0001976) | 2.30782719 |
| 72 | Neonatal onset (HP:0003623) | 2.28801560 |
| 73 | Neonatal hypoglycemia (HP:0001998) | 2.28346271 |
| 74 | Cerebral edema (HP:0002181) | 2.28248935 |
| 75 | Abnormal gallbladder physiology (HP:0012438) | 2.26119754 |
| 76 | Cholecystitis (HP:0001082) | 2.26119754 |
| 77 | Esophageal varix (HP:0002040) | 2.23048670 |
| 78 | * Irritability (HP:0000737) | 2.22897459 |
| 79 | Thrombophlebitis (HP:0004418) | 2.19428814 |
| 80 | Increased serum ferritin (HP:0003281) | 2.18813367 |
| 81 | Pancreatitis (HP:0001733) | 2.16834139 |
| 82 | Elevated alkaline phosphatase (HP:0003155) | 2.14017555 |
| 83 | Malnutrition (HP:0004395) | 2.12467347 |
| 84 | Nephritis (HP:0000123) | 2.11243804 |
| 85 | Late onset (HP:0003584) | 2.10975892 |
| 86 | Sensorimotor neuropathy (HP:0007141) | 2.08356192 |
| 87 | Brushfield spots (HP:0001088) | 2.07851055 |
| 88 | Arthropathy (HP:0003040) | 2.07747306 |
| 89 | Joint swelling (HP:0001386) | 2.07233725 |
| 90 | Abnormality of iron homeostasis (HP:0011031) | 2.02529776 |
| 91 | Hemorrhage of the eye (HP:0011885) | 2.01996526 |
| 92 | Generalized aminoaciduria (HP:0002909) | 1.97688798 |
| 93 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.95880077 |
| 94 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.95525256 |
| 95 | Opisthotonus (HP:0002179) | 1.94722749 |
| 96 | Increased mean platelet volume (HP:0011877) | 1.94337196 |
| 97 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.93137782 |
| 98 | Enlarged kidneys (HP:0000105) | 1.93040483 |
| 99 | Abnormality of the gallbladder (HP:0005264) | 1.91700139 |
| 100 | * Vomiting (HP:0002013) | 1.91415880 |
| 101 | Abnormal platelet volume (HP:0011876) | 1.88873810 |
| 102 | Rickets (HP:0002748) | 1.88598726 |
| 103 | Pulmonary embolism (HP:0002204) | 1.88046478 |
| 104 | Hypochromic anemia (HP:0001931) | 1.87500268 |
| 105 | Poikilocytosis (HP:0004447) | 1.86472082 |
| 106 | Generalized hypopigmentation of hair (HP:0011358) | 1.85796445 |
| 107 | Abnormality of the Achilles tendon (HP:0005109) | 1.85171781 |
| 108 | Hydroxyprolinuria (HP:0003080) | 1.81023791 |
| 109 | Abnormality of proline metabolism (HP:0010907) | 1.81023791 |
| 110 | Alkalosis (HP:0001948) | 1.80582727 |
| 111 | Hyperphosphaturia (HP:0003109) | 1.78933173 |
| 112 | Hypophosphatemic rickets (HP:0004912) | 1.78709691 |
| 113 | Abnormal cartilage morphology (HP:0002763) | 1.78634313 |
| 114 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.77834653 |
| 115 | Elevated hepatic transaminases (HP:0002910) | 1.74257992 |
| 116 | Hyperglycemia (HP:0003074) | 1.73838016 |
| 117 | Renal cortical cysts (HP:0000803) | 1.70994661 |
| 118 | Abnormal platelet function (HP:0011869) | 1.69392335 |
| 119 | Impaired platelet aggregation (HP:0003540) | 1.69392335 |
| 120 | Abnormal biliary tract physiology (HP:0012439) | 1.66196556 |
| 121 | Bile duct proliferation (HP:0001408) | 1.66196556 |
| 122 | Status epilepticus (HP:0002133) | 1.66090658 |
| 123 | Abnormality of vitamin metabolism (HP:0100508) | 1.65050764 |
| 124 | Periodontitis (HP:0000704) | 1.64180337 |
| 125 | Pruritus (HP:0000989) | 1.64087939 |
| 126 | Reticulocytosis (HP:0001923) | 1.63918761 |
| 127 | Polycythemia (HP:0001901) | 1.63345201 |
| 128 | Abnormality of urine glucose concentration (HP:0011016) | 1.61912560 |
| 129 | Glycosuria (HP:0003076) | 1.61912560 |
| 130 | Increased IgE level (HP:0003212) | 1.61058115 |
| 131 | Atrioventricular block (HP:0001678) | 1.58616841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.19730366 |
| 2 | ERN1 | 4.26292749 |
| 3 | FGFR4 | 4.20411579 |
| 4 | SIK1 | 3.91177385 |
| 5 | TAOK3 | 3.37881950 |
| 6 | PKN2 | 2.68848258 |
| 7 | INSRR | 2.59505878 |
| 8 | MST1R | 2.58749097 |
| 9 | PRPF4B | 2.58137926 |
| 10 | ERBB4 | 2.51160232 |
| 11 | MAP3K6 | 2.18762277 |
| 12 | FLT3 | 2.10128673 |
| 13 | TYK2 | 1.99402586 |
| 14 | MAP2K4 | 1.96489872 |
| 15 | PIK3CG | 1.93695595 |
| 16 | TRIB3 | 1.89706754 |
| 17 | PIK3CA | 1.89337041 |
| 18 | ABL2 | 1.79987227 |
| 19 | BLK | 1.78473532 |
| 20 | MAPK11 | 1.69808444 |
| 21 | MAP3K2 | 1.69274770 |
| 22 | TNK2 | 1.62637701 |
| 23 | PTK6 | 1.61588274 |
| 24 | DAPK2 | 1.49504820 |
| 25 | MAP3K14 | 1.48095170 |
| 26 | FRK | 1.46253924 |
| 27 | EPHB1 | 1.45905544 |
| 28 | NEK9 | 1.43357012 |
| 29 | RIPK4 | 1.42251584 |
| 30 | GRK6 | 1.33949956 |
| 31 | TBK1 | 1.30908381 |
| 32 | JAK2 | 1.28901738 |
| 33 | IRAK3 | 1.27826817 |
| 34 | LATS1 | 1.26907494 |
| 35 | IRAK4 | 1.17400328 |
| 36 | TAOK2 | 1.15852458 |
| 37 | ERBB2 | 1.15563764 |
| 38 | NLK | 1.13276519 |
| 39 | JAK1 | 1.12912868 |
| 40 | KDR | 1.11137070 |
| 41 | KSR2 | 1.09861448 |
| 42 | TAOK1 | 1.09579242 |
| 43 | EPHA2 | 1.06368382 |
| 44 | RIPK1 | 1.05810008 |
| 45 | PINK1 | 1.05206291 |
| 46 | MAP3K7 | 1.05052806 |
| 47 | CSK | 1.04148879 |
| 48 | FGFR2 | 1.04063278 |
| 49 | MET | 1.02548513 |
| 50 | MAPK4 | 0.97782052 |
| 51 | EPHA3 | 0.97594721 |
| 52 | CDK6 | 0.96921318 |
| 53 | MAP2K3 | 0.95854454 |
| 54 | CSF1R | 0.92587783 |
| 55 | SYK | 0.90900105 |
| 56 | PRKAA2 | 0.90135268 |
| 57 | FES | 0.88651091 |
| 58 | MAPK15 | 0.88632111 |
| 59 | MAP3K3 | 0.84073754 |
| 60 | TEC | 0.81971003 |
| 61 | PTK2 | 0.79625418 |
| 62 | SGK2 | 0.79498143 |
| 63 | MAP3K13 | 0.77422594 |
| 64 | MAP3K10 | 0.76107627 |
| 65 | HCK | 0.75966836 |
| 66 | CAMK1D | 0.75521503 |
| 67 | PRKACG | 0.75409246 |
| 68 | TRPM7 | 0.74214416 |
| 69 | FER | 0.74198567 |
| 70 | CDK12 | 0.74110858 |
| 71 | BMX | 0.73586492 |
| 72 | PRKCZ | 0.73122029 |
| 73 | CAMKK2 | 0.72889041 |
| 74 | IKBKE | 0.70647459 |
| 75 | FGFR3 | 0.70237382 |
| 76 | DYRK1B | 0.69321384 |
| 77 | GSK3A | 0.67896717 |
| 78 | MAP3K11 | 0.67542084 |
| 79 | CAMK2G | 0.67447088 |
| 80 | ARAF | 0.66129621 |
| 81 | MAPK12 | 0.65101501 |
| 82 | NTRK3 | 0.64569270 |
| 83 | SGK494 | 0.64333849 |
| 84 | SGK223 | 0.64333849 |
| 85 | YES1 | 0.62024591 |
| 86 | PBK | 0.60735417 |
| 87 | IGF1R | 0.59647638 |
| 88 | SGK1 | 0.58111858 |
| 89 | ZAP70 | 0.56223722 |
| 90 | PRKG1 | 0.55665340 |
| 91 | TGFBR2 | 0.54874379 |
| 92 | TXK | 0.54621514 |
| 93 | SGK3 | 0.53006986 |
| 94 | PRKCG | 0.52820216 |
| 95 | MAP4K1 | 0.52256663 |
| 96 | EGFR | 0.50470553 |
| 97 | MAP2K6 | 0.49845914 |
| 98 | PDPK1 | 0.48978067 |
| 99 | PRKCQ | 0.48314823 |
| 100 | LCK | 0.48289607 |
| 101 | PRKAA1 | 0.45501068 |
| 102 | RAF1 | 0.44390161 |
| 103 | AKT3 | 0.44241306 |
| 104 | EPHB2 | 0.42693806 |
| 105 | PRKACA | 0.41718522 |
| 106 | STK38L | 0.41460595 |
| 107 | STK3 | 0.41338535 |
| 108 | EIF2AK1 | 0.40410704 |
| 109 | MAPK7 | 0.40369997 |
| 110 | MAP2K1 | 0.38860629 |
| 111 | TIE1 | 0.38408330 |
| 112 | MARK2 | 0.38096963 |
| 113 | ABL1 | 0.37724686 |
| 114 | KIT | 0.36108320 |
| 115 | PRKCB | 0.35400442 |
| 116 | CSNK1D | 0.34779470 |
| 117 | BTK | 0.33270492 |
| 118 | CSNK1G1 | 0.33226503 |
| 119 | IKBKB | 0.31440140 |
| 120 | MAP3K1 | 0.31138341 |
| 121 | PKN1 | 0.30796918 |
| 122 | RET | 0.30784811 |
| 123 | PDK1 | 0.30581250 |
| 124 | LYN | 0.29338560 |
| 125 | GRK1 | 0.28261426 |
| 126 | CDK4 | 0.27853641 |
| 127 | JAK3 | 0.25650350 |
| 128 | FGFR1 | 0.25276481 |
| 129 | PRKD1 | 0.24917146 |
| 130 | CAMK1G | 0.24327157 |
| 131 | CHUK | 0.23599428 |
| 132 | PRKCA | 0.22872155 |
| 133 | MAP2K2 | 0.22556282 |
| 134 | ITK | 0.22526245 |
| 135 | MAP3K5 | 0.22494105 |
| 136 | IRAK1 | 0.20990543 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.51601123 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.56006384 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.43234095 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.34750497 |
| 5 | * Arginine biosynthesis_Homo sapiens_hsa00220 | 3.04240951 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.99526117 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.65494444 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.62357207 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.53035316 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.49570012 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.43136261 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.30839693 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.29492712 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.20673119 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.19825227 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.06344229 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.02487796 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.01324884 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.00132873 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.97087188 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.91192913 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.89959620 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86260415 |
| 24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.83991381 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.79725861 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.74562330 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71321362 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.71109355 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.71100455 |
| 30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.66263926 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.58124147 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.49412641 |
| 33 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.46224881 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.45967054 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.45336400 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.45090605 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.44242606 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34628956 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30605828 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28827026 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.28538267 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.26886965 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22267471 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.17069050 |
| 45 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.15072732 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14283239 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.12659126 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.09721722 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02751075 |
| 50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00516939 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.95958799 |
| 52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91544082 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 0.87826539 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.87523614 |
| 55 | * Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.85134850 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.84345395 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84107633 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76371008 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.75036246 |
| 60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71009396 |
| 61 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.68790722 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.68560208 |
| 63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64976235 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63760432 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49414779 |
| 66 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47340215 |
| 67 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.43213310 |
| 68 | Prion diseases_Homo sapiens_hsa05020 | 0.42881662 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.38988047 |
| 70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32524904 |
| 71 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.30829121 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22376965 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21577183 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.21148860 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20883379 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11308151 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.09915783 |
| 78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08832091 |
| 79 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.07361175 |
| 80 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.06242639 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.06074203 |
| 82 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2129121 |
| 83 | * Amoebiasis_Homo sapiens_hsa05146 | -0.2108293 |
| 84 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1885377 |
| 85 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1812760 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1740312 |
| 87 | Leishmaniasis_Homo sapiens_hsa05140 | -0.1708239 |
| 88 | Malaria_Homo sapiens_hsa05144 | -0.1690652 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1681333 |
| 90 | Hepatitis C_Homo sapiens_hsa05160 | -0.1640382 |
| 91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1577855 |
| 92 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1554070 |
| 93 | Platelet activation_Homo sapiens_hsa04611 | -0.1505614 |
| 94 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1487125 |
| 95 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1483224 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1386603 |
| 97 | Mineral absorption_Homo sapiens_hsa04978 | -0.1313983 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1222081 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1178985 |
| 100 | Legionellosis_Homo sapiens_hsa05134 | -0.1150224 |
| 101 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1099721 |
| 102 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0901838 |
| 103 | Lysosome_Homo sapiens_hsa04142 | -0.0849820 |
| 104 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0747167 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0738551 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0528395 |
| 107 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0340127 |
| 108 | Pertussis_Homo sapiens_hsa05133 | -0.0322760 |
| 109 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0292854 |

